News & Events

• Filter by:
• All
• News
• Events
• Archive

• news

  May 6, 2025

  Almac Discovery and Formosa Pharmaceuticals announce global licensing agreement for development and commercialisation of ALM-401, a first-in-class EGFRxROR1 Bispecific Antibody-Drug Conjugate

  Read more

• news

  December 4, 2024

  Almac announces key partnership with Future Medicines Institute

  Read more

• news

  May 30, 2024

  Almac Discovery nominates ALM-401 as a First in Class Bispecific Next Generation ADC targeting EGFR/ROR1 to progress into pre-clinical development

  Read more

• events

  January 16, 2024

  PepTalk: Developability of Bispecific Antibodies

  Read more

• news

  November 29, 2023

  Almac Discovery and Queen’s University launch state-of-the-art Chemoproteomics facility in Belfast

  Read more

• events

  September 28, 2023

  Cancer Cachexia Society Conference

  Read more

• events

  July 14, 2023

  RSC Organic Chemistry Ireland Meeting 2023

  Read more

• news

  June 6, 2023

  WEE1 Inhibitor discovered by Almac Discovery advanced into two clinical studies addressing the treatment of advanced solid tumours 

  Read more